Pharma & Healthcare
Global Long-Acting Contraceptive Pills Market Research Report 2026
- Feb 24, 26
- ID: 717829
- Pages: 109
- Figures: 113
- Views: 2
This report delivers a comprehensive overview of the global Long-Acting Contraceptive Pills market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Long-Acting Contraceptive Pills. The Long-Acting Contraceptive Pills market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Long-Acting Contraceptive Pills market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Long-Acting Contraceptive Pills manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Zhejiang Xianju Pharmaceutical
Pfizer
Mylan
Teva Pharmaceuticals
Cipla
Bayer
Merck
Sun Pharma
Shanghai Pharmaceuticals
Segment by Type
Injectables
Subdermal Implants
Intrauterine Devices
Other
by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Long-Acting Contraceptive Pills manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Long-Acting Contraceptive Pills sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Long-Acting Contraceptive Pills market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Long-Acting Contraceptive Pills manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Zhejiang Xianju Pharmaceutical
Pfizer
Mylan
Teva Pharmaceuticals
Cipla
Bayer
Merck
Sun Pharma
Shanghai Pharmaceuticals
Segment by Type
Injectables
Subdermal Implants
Intrauterine Devices
Other
by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Long-Acting Contraceptive Pills manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Long-Acting Contraceptive Pills sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Long-Acting Contraceptive Pills Market Overview
1.1 Product Definition
1.2 Long-Acting Contraceptive Pills by Type
1.2.1 Global Long-Acting Contraceptive Pills Market Value by Type: 2025 vs 2032
1.2.2 Injectables
1.2.3 Subdermal Implants
1.2.4 Intrauterine Devices
1.2.5 Other
1.3 Long-Acting Contraceptive Pills by Application
1.3.1 Global Long-Acting Contraceptive Pills Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Long-Acting Contraceptive Pills Market Size Estimates and Forecasts
1.4.1 Global Long-Acting Contraceptive Pills Revenue 2021–2032
1.4.2 Global Long-Acting Contraceptive Pills Sales 2021–2032
1.4.3 Global Long-Acting Contraceptive Pills Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Long-Acting Contraceptive Pills Market Competition by Manufacturers
2.1 Global Long-Acting Contraceptive Pills Sales Market Share by Manufacturers (2021–2026)
2.2 Global Long-Acting Contraceptive Pills Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Long-Acting Contraceptive Pills Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Long-Acting Contraceptive Pills, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Long-Acting Contraceptive Pills, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Long-Acting Contraceptive Pills, Product Types and Applications
2.7 Global Key Manufacturers of Long-Acting Contraceptive Pills, Date of Entry into the Industry
2.8 Global Long-Acting Contraceptive Pills Market Competitive Situation and Trends
2.8.1 Global Long-Acting Contraceptive Pills Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Long-Acting Contraceptive Pills Players Market Share by Revenue
2.8.3 Global Long-Acting Contraceptive Pills Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Long-Acting Contraceptive Pills Market Scenario by Region
3.1 Global Long-Acting Contraceptive Pills Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Long-Acting Contraceptive Pills Sales by Region: 2021–2032
3.2.1 Global Long-Acting Contraceptive Pills Sales by Region: 2021–2026
3.2.2 Global Long-Acting Contraceptive Pills Sales by Region: 2027–2032
3.3 Global Long-Acting Contraceptive Pills Revenue by Region: 2021–2032
3.3.1 Global Long-Acting Contraceptive Pills Revenue by Region: 2021–2026
3.3.2 Global Long-Acting Contraceptive Pills Revenue by Region: 2027–2032
3.4 North America Long-Acting Contraceptive Pills Market Facts & Figures by Country
3.4.1 North America Long-Acting Contraceptive Pills Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Long-Acting Contraceptive Pills Sales by Country (2021–2032)
3.4.3 North America Long-Acting Contraceptive Pills Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Long-Acting Contraceptive Pills Market Facts & Figures by Country
3.5.1 Europe Long-Acting Contraceptive Pills Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Long-Acting Contraceptive Pills Sales by Country (2021–2032)
3.5.3 Europe Long-Acting Contraceptive Pills Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Long-Acting Contraceptive Pills Market Facts & Figures by Region
3.6.1 Asia Pacific Long-Acting Contraceptive Pills Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Long-Acting Contraceptive Pills Sales by Region (2021–2032)
3.6.3 Asia Pacific Long-Acting Contraceptive Pills Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Long-Acting Contraceptive Pills Market Facts & Figures by Country
3.7.1 Latin America Long-Acting Contraceptive Pills Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Long-Acting Contraceptive Pills Sales by Country (2021–2032)
3.7.3 Latin America Long-Acting Contraceptive Pills Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Long-Acting Contraceptive Pills Market Facts & Figures by Country
3.8.1 Middle East and Africa Long-Acting Contraceptive Pills Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Long-Acting Contraceptive Pills Sales by Country (2021–2032)
3.8.3 Middle East and Africa Long-Acting Contraceptive Pills Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Long-Acting Contraceptive Pills Sales by Type (2021–2032)
4.1.1 Global Long-Acting Contraceptive Pills Sales by Type (2021–2026)
4.1.2 Global Long-Acting Contraceptive Pills Sales by Type (2027–2032)
4.1.3 Global Long-Acting Contraceptive Pills Sales Market Share by Type (2021–2032)
4.2 Global Long-Acting Contraceptive Pills Revenue by Type (2021–2032)
4.2.1 Global Long-Acting Contraceptive Pills Revenue by Type (2021–2026)
4.2.2 Global Long-Acting Contraceptive Pills Revenue by Type (2027–2032)
4.2.3 Global Long-Acting Contraceptive Pills Revenue Market Share by Type (2021–2032)
4.3 Global Long-Acting Contraceptive Pills Price by Type (2021–2032)
5 Segment by Application
5.1 Global Long-Acting Contraceptive Pills Sales by Application (2021–2032)
5.1.1 Global Long-Acting Contraceptive Pills Sales by Application (2021–2026)
5.1.2 Global Long-Acting Contraceptive Pills Sales by Application (2027–2032)
5.1.3 Global Long-Acting Contraceptive Pills Sales Market Share by Application (2021–2032)
5.2 Global Long-Acting Contraceptive Pills Revenue by Application (2021–2032)
5.2.1 Global Long-Acting Contraceptive Pills Revenue by Application (2021–2026)
5.2.2 Global Long-Acting Contraceptive Pills Revenue by Application (2027–2032)
5.2.3 Global Long-Acting Contraceptive Pills Revenue Market Share by Application (2021–2032)
5.3 Global Long-Acting Contraceptive Pills Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Zhejiang Xianju Pharmaceutical
6.1.1 Zhejiang Xianju Pharmaceutical Company Information
6.1.2 Zhejiang Xianju Pharmaceutical Description and Business Overview
6.1.3 Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Product Portfolio
6.1.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Long-Acting Contraceptive Pills Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Pfizer Long-Acting Contraceptive Pills Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Company Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Long-Acting Contraceptive Pills Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Mylan Long-Acting Contraceptive Pills Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Teva Pharmaceuticals
6.4.1 Teva Pharmaceuticals Company Information
6.4.2 Teva Pharmaceuticals Description and Business Overview
6.4.3 Teva Pharmaceuticals Long-Acting Contraceptive Pills Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Teva Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolio
6.4.5 Teva Pharmaceuticals Recent Developments/Updates
6.5 Cipla
6.5.1 Cipla Company Information
6.5.2 Cipla Description and Business Overview
6.5.3 Cipla Long-Acting Contraceptive Pills Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Cipla Long-Acting Contraceptive Pills Product Portfolio
6.5.5 Cipla Recent Developments/Updates
6.6 Bayer
6.6.1 Bayer Company Information
6.6.2 Bayer Description and Business Overview
6.6.3 Bayer Long-Acting Contraceptive Pills Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Bayer Long-Acting Contraceptive Pills Product Portfolio
6.6.5 Bayer Recent Developments/Updates
6.7 Merck
6.7.1 Merck Company Information
6.7.2 Merck Description and Business Overview
6.7.3 Merck Long-Acting Contraceptive Pills Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Merck Long-Acting Contraceptive Pills Product Portfolio
6.7.5 Merck Recent Developments/Updates
6.8 Sun Pharma
6.8.1 Sun Pharma Company Information
6.8.2 Sun Pharma Description and Business Overview
6.8.3 Sun Pharma Long-Acting Contraceptive Pills Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Sun Pharma Long-Acting Contraceptive Pills Product Portfolio
6.8.5 Sun Pharma Recent Developments/Updates
6.9 Shanghai Pharmaceuticals
6.9.1 Shanghai Pharmaceuticals Company Information
6.9.2 Shanghai Pharmaceuticals Description and Business Overview
6.9.3 Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolio
6.9.5 Shanghai Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Long-Acting Contraceptive Pills Industry Chain Analysis
7.2 Long-Acting Contraceptive Pills Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Long-Acting Contraceptive Pills Production Mode & Process Analysis
7.4 Long-Acting Contraceptive Pills Sales and Marketing
7.4.1 Long-Acting Contraceptive Pills Sales Channels
7.4.2 Long-Acting Contraceptive Pills Distributors
7.5 Long-Acting Contraceptive Pills Customer Analysis
8 Long-Acting Contraceptive Pills Market Dynamics
8.1 Long-Acting Contraceptive Pills Industry Trends
8.2 Long-Acting Contraceptive Pills Market Drivers
8.3 Long-Acting Contraceptive Pills Market Challenges
8.4 Long-Acting Contraceptive Pills Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Long-Acting Contraceptive Pills by Type
1.2.1 Global Long-Acting Contraceptive Pills Market Value by Type: 2025 vs 2032
1.2.2 Injectables
1.2.3 Subdermal Implants
1.2.4 Intrauterine Devices
1.2.5 Other
1.3 Long-Acting Contraceptive Pills by Application
1.3.1 Global Long-Acting Contraceptive Pills Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Long-Acting Contraceptive Pills Market Size Estimates and Forecasts
1.4.1 Global Long-Acting Contraceptive Pills Revenue 2021–2032
1.4.2 Global Long-Acting Contraceptive Pills Sales 2021–2032
1.4.3 Global Long-Acting Contraceptive Pills Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Long-Acting Contraceptive Pills Market Competition by Manufacturers
2.1 Global Long-Acting Contraceptive Pills Sales Market Share by Manufacturers (2021–2026)
2.2 Global Long-Acting Contraceptive Pills Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Long-Acting Contraceptive Pills Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Long-Acting Contraceptive Pills, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Long-Acting Contraceptive Pills, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Long-Acting Contraceptive Pills, Product Types and Applications
2.7 Global Key Manufacturers of Long-Acting Contraceptive Pills, Date of Entry into the Industry
2.8 Global Long-Acting Contraceptive Pills Market Competitive Situation and Trends
2.8.1 Global Long-Acting Contraceptive Pills Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Long-Acting Contraceptive Pills Players Market Share by Revenue
2.8.3 Global Long-Acting Contraceptive Pills Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Long-Acting Contraceptive Pills Market Scenario by Region
3.1 Global Long-Acting Contraceptive Pills Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Long-Acting Contraceptive Pills Sales by Region: 2021–2032
3.2.1 Global Long-Acting Contraceptive Pills Sales by Region: 2021–2026
3.2.2 Global Long-Acting Contraceptive Pills Sales by Region: 2027–2032
3.3 Global Long-Acting Contraceptive Pills Revenue by Region: 2021–2032
3.3.1 Global Long-Acting Contraceptive Pills Revenue by Region: 2021–2026
3.3.2 Global Long-Acting Contraceptive Pills Revenue by Region: 2027–2032
3.4 North America Long-Acting Contraceptive Pills Market Facts & Figures by Country
3.4.1 North America Long-Acting Contraceptive Pills Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Long-Acting Contraceptive Pills Sales by Country (2021–2032)
3.4.3 North America Long-Acting Contraceptive Pills Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Long-Acting Contraceptive Pills Market Facts & Figures by Country
3.5.1 Europe Long-Acting Contraceptive Pills Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Long-Acting Contraceptive Pills Sales by Country (2021–2032)
3.5.3 Europe Long-Acting Contraceptive Pills Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Long-Acting Contraceptive Pills Market Facts & Figures by Region
3.6.1 Asia Pacific Long-Acting Contraceptive Pills Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Long-Acting Contraceptive Pills Sales by Region (2021–2032)
3.6.3 Asia Pacific Long-Acting Contraceptive Pills Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Long-Acting Contraceptive Pills Market Facts & Figures by Country
3.7.1 Latin America Long-Acting Contraceptive Pills Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Long-Acting Contraceptive Pills Sales by Country (2021–2032)
3.7.3 Latin America Long-Acting Contraceptive Pills Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Long-Acting Contraceptive Pills Market Facts & Figures by Country
3.8.1 Middle East and Africa Long-Acting Contraceptive Pills Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Long-Acting Contraceptive Pills Sales by Country (2021–2032)
3.8.3 Middle East and Africa Long-Acting Contraceptive Pills Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Long-Acting Contraceptive Pills Sales by Type (2021–2032)
4.1.1 Global Long-Acting Contraceptive Pills Sales by Type (2021–2026)
4.1.2 Global Long-Acting Contraceptive Pills Sales by Type (2027–2032)
4.1.3 Global Long-Acting Contraceptive Pills Sales Market Share by Type (2021–2032)
4.2 Global Long-Acting Contraceptive Pills Revenue by Type (2021–2032)
4.2.1 Global Long-Acting Contraceptive Pills Revenue by Type (2021–2026)
4.2.2 Global Long-Acting Contraceptive Pills Revenue by Type (2027–2032)
4.2.3 Global Long-Acting Contraceptive Pills Revenue Market Share by Type (2021–2032)
4.3 Global Long-Acting Contraceptive Pills Price by Type (2021–2032)
5 Segment by Application
5.1 Global Long-Acting Contraceptive Pills Sales by Application (2021–2032)
5.1.1 Global Long-Acting Contraceptive Pills Sales by Application (2021–2026)
5.1.2 Global Long-Acting Contraceptive Pills Sales by Application (2027–2032)
5.1.3 Global Long-Acting Contraceptive Pills Sales Market Share by Application (2021–2032)
5.2 Global Long-Acting Contraceptive Pills Revenue by Application (2021–2032)
5.2.1 Global Long-Acting Contraceptive Pills Revenue by Application (2021–2026)
5.2.2 Global Long-Acting Contraceptive Pills Revenue by Application (2027–2032)
5.2.3 Global Long-Acting Contraceptive Pills Revenue Market Share by Application (2021–2032)
5.3 Global Long-Acting Contraceptive Pills Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Zhejiang Xianju Pharmaceutical
6.1.1 Zhejiang Xianju Pharmaceutical Company Information
6.1.2 Zhejiang Xianju Pharmaceutical Description and Business Overview
6.1.3 Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Product Portfolio
6.1.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Long-Acting Contraceptive Pills Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Pfizer Long-Acting Contraceptive Pills Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Company Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Long-Acting Contraceptive Pills Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Mylan Long-Acting Contraceptive Pills Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Teva Pharmaceuticals
6.4.1 Teva Pharmaceuticals Company Information
6.4.2 Teva Pharmaceuticals Description and Business Overview
6.4.3 Teva Pharmaceuticals Long-Acting Contraceptive Pills Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Teva Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolio
6.4.5 Teva Pharmaceuticals Recent Developments/Updates
6.5 Cipla
6.5.1 Cipla Company Information
6.5.2 Cipla Description and Business Overview
6.5.3 Cipla Long-Acting Contraceptive Pills Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Cipla Long-Acting Contraceptive Pills Product Portfolio
6.5.5 Cipla Recent Developments/Updates
6.6 Bayer
6.6.1 Bayer Company Information
6.6.2 Bayer Description and Business Overview
6.6.3 Bayer Long-Acting Contraceptive Pills Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Bayer Long-Acting Contraceptive Pills Product Portfolio
6.6.5 Bayer Recent Developments/Updates
6.7 Merck
6.7.1 Merck Company Information
6.7.2 Merck Description and Business Overview
6.7.3 Merck Long-Acting Contraceptive Pills Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Merck Long-Acting Contraceptive Pills Product Portfolio
6.7.5 Merck Recent Developments/Updates
6.8 Sun Pharma
6.8.1 Sun Pharma Company Information
6.8.2 Sun Pharma Description and Business Overview
6.8.3 Sun Pharma Long-Acting Contraceptive Pills Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Sun Pharma Long-Acting Contraceptive Pills Product Portfolio
6.8.5 Sun Pharma Recent Developments/Updates
6.9 Shanghai Pharmaceuticals
6.9.1 Shanghai Pharmaceuticals Company Information
6.9.2 Shanghai Pharmaceuticals Description and Business Overview
6.9.3 Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolio
6.9.5 Shanghai Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Long-Acting Contraceptive Pills Industry Chain Analysis
7.2 Long-Acting Contraceptive Pills Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Long-Acting Contraceptive Pills Production Mode & Process Analysis
7.4 Long-Acting Contraceptive Pills Sales and Marketing
7.4.1 Long-Acting Contraceptive Pills Sales Channels
7.4.2 Long-Acting Contraceptive Pills Distributors
7.5 Long-Acting Contraceptive Pills Customer Analysis
8 Long-Acting Contraceptive Pills Market Dynamics
8.1 Long-Acting Contraceptive Pills Industry Trends
8.2 Long-Acting Contraceptive Pills Market Drivers
8.3 Long-Acting Contraceptive Pills Market Challenges
8.4 Long-Acting Contraceptive Pills Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Long-Acting Contraceptive Pills Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Long-Acting Contraceptive Pills Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Long-Acting Contraceptive Pills Market Competitive Situation by Manufacturers in 2025
Table 4. Global Long-Acting Contraceptive Pills Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Long-Acting Contraceptive Pills Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Long-Acting Contraceptive Pills Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Long-Acting Contraceptive Pills Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Long-Acting Contraceptive Pills Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Long-Acting Contraceptive Pills, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Long-Acting Contraceptive Pills, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Long-Acting Contraceptive Pills, Product Types and Applications
Table 12. Global Key Manufacturers of Long-Acting Contraceptive Pills, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Long-Acting Contraceptive Pills Companies by Tier (Tier 1, Tier 2, Tier 3), based on Long-Acting Contraceptive Pills Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Long-Acting Contraceptive Pills Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Long-Acting Contraceptive Pills Sales by Region (K Units), 2021–2026
Table 18. Global Long-Acting Contraceptive Pills Sales Market Share by Region (2021–2026)
Table 19. Global Long-Acting Contraceptive Pills Sales by Region (K Units), 2027–2032
Table 20. Global Long-Acting Contraceptive Pills Sales Market Share by Region (2027–2032)
Table 21. Global Long-Acting Contraceptive Pills Revenue by Region (US$ Million), 2021–2026
Table 22. Global Long-Acting Contraceptive Pills Revenue Market Share by Region (2021–2026)
Table 23. Global Long-Acting Contraceptive Pills Revenue by Region (US$ Million), 2027–2032
Table 24. Global Long-Acting Contraceptive Pills Revenue Market Share by Region (2027–2032)
Table 25. North America Long-Acting Contraceptive Pills Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Long-Acting Contraceptive Pills Sales by Country (K Units), 2021–2026
Table 27. North America Long-Acting Contraceptive Pills Sales by Country (K Units), 2027–2032
Table 28. North America Long-Acting Contraceptive Pills Revenue by Country (US$ Million), 2021–2026
Table 29. North America Long-Acting Contraceptive Pills Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Long-Acting Contraceptive Pills Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Long-Acting Contraceptive Pills Sales by Country (K Units), 2021–2026
Table 32. Europe Long-Acting Contraceptive Pills Sales by Country (K Units), 2027–2032
Table 33. Europe Long-Acting Contraceptive Pills Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Long-Acting Contraceptive Pills Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Long-Acting Contraceptive Pills Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Long-Acting Contraceptive Pills Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Long-Acting Contraceptive Pills Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Long-Acting Contraceptive Pills Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Long-Acting Contraceptive Pills Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Long-Acting Contraceptive Pills Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Long-Acting Contraceptive Pills Sales by Country (K Units), 2021–2026
Table 42. Latin America Long-Acting Contraceptive Pills Sales by Country (K Units), 2027–2032
Table 43. Latin America Long-Acting Contraceptive Pills Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Long-Acting Contraceptive Pills Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Long-Acting Contraceptive Pills Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Long-Acting Contraceptive Pills Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Long-Acting Contraceptive Pills Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Long-Acting Contraceptive Pills Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Long-Acting Contraceptive Pills Revenue by Country (US$ Million), 2027–2032
Table 50. Global Long-Acting Contraceptive Pills Sales (K Units) by Type (2021–2026)
Table 51. Global Long-Acting Contraceptive Pills Sales (K Units) by Type (2027–2032)
Table 52. Global Long-Acting Contraceptive Pills Sales Market Share by Type (2021–2026)
Table 53. Global Long-Acting Contraceptive Pills Sales Market Share by Type (2027–2032)
Table 54. Global Long-Acting Contraceptive Pills Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Long-Acting Contraceptive Pills Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Long-Acting Contraceptive Pills Revenue Market Share by Type (2021–2026)
Table 57. Global Long-Acting Contraceptive Pills Revenue Market Share by Type (2027–2032)
Table 58. Global Long-Acting Contraceptive Pills Price (US$/Unit) by Type (2021–2026)
Table 59. Global Long-Acting Contraceptive Pills Price (US$/Unit) by Type (2027–2032)
Table 60. Global Long-Acting Contraceptive Pills Sales (K Units) by Application (2021–2026)
Table 61. Global Long-Acting Contraceptive Pills Sales (K Units) by Application (2027–2032)
Table 62. Global Long-Acting Contraceptive Pills Sales Market Share by Application (2021–2026)
Table 63. Global Long-Acting Contraceptive Pills Sales Market Share by Application (2027–2032)
Table 64. Global Long-Acting Contraceptive Pills Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Long-Acting Contraceptive Pills Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Long-Acting Contraceptive Pills Revenue Market Share by Application (2021–2026)
Table 67. Global Long-Acting Contraceptive Pills Revenue Market Share by Application (2027–2032)
Table 68. Global Long-Acting Contraceptive Pills Price (US$/Unit) by Application (2021–2026)
Table 69. Global Long-Acting Contraceptive Pills Price (US$/Unit) by Application (2027–2032)
Table 70. Zhejiang Xianju Pharmaceutical Company Information
Table 71. Zhejiang Xianju Pharmaceutical Description and Business Overview
Table 72. Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Product
Table 74. Zhejiang Xianju Pharmaceutical Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Pfizer Long-Acting Contraceptive Pills Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Mylan Company Information
Table 81. Mylan Description and Business Overview
Table 82. Mylan Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Mylan Long-Acting Contraceptive Pills Product
Table 84. Mylan Recent Developments/Updates
Table 85. Teva Pharmaceuticals Company Information
Table 86. Teva Pharmaceuticals Description and Business Overview
Table 87. Teva Pharmaceuticals Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Teva Pharmaceuticals Long-Acting Contraceptive Pills Product
Table 89. Teva Pharmaceuticals Recent Developments/Updates
Table 90. Cipla Company Information
Table 91. Cipla Description and Business Overview
Table 92. Cipla Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Cipla Long-Acting Contraceptive Pills Product
Table 94. Cipla Recent Developments/Updates
Table 95. Bayer Company Information
Table 96. Bayer Description and Business Overview
Table 97. Bayer Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Bayer Long-Acting Contraceptive Pills Product
Table 99. Bayer Recent Developments/Updates
Table 100. Merck Company Information
Table 101. Merck Description and Business Overview
Table 102. Merck Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Merck Long-Acting Contraceptive Pills Product
Table 104. Merck Recent Developments/Updates
Table 105. Sun Pharma Company Information
Table 106. Sun Pharma Description and Business Overview
Table 107. Sun Pharma Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Sun Pharma Long-Acting Contraceptive Pills Product
Table 109. Sun Pharma Recent Developments/Updates
Table 110. Shanghai Pharmaceuticals Company Information
Table 111. Shanghai Pharmaceuticals Description and Business Overview
Table 112. Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Product
Table 114. Shanghai Pharmaceuticals Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Long-Acting Contraceptive Pills Distributors List
Table 118. Long-Acting Contraceptive Pills Customers List
Table 119. Long-Acting Contraceptive Pills Market Trends
Table 120. Long-Acting Contraceptive Pills Market Drivers
Table 121. Long-Acting Contraceptive Pills Market Challenges
Table 122. Long-Acting Contraceptive Pills Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Long-Acting Contraceptive Pills
Figure 2. Global Long-Acting Contraceptive Pills Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Long-Acting Contraceptive Pills Market Share by Type: 2025 & 2032
Figure 4. Injectables Product Picture
Figure 5. Subdermal Implants Product Picture
Figure 6. Intrauterine Devices Product Picture
Figure 7. Other Product Picture
Figure 8. Global Long-Acting Contraceptive Pills Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Long-Acting Contraceptive Pills Market Share by Application: 2025 & 2032
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Global Long-Acting Contraceptive Pills Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Long-Acting Contraceptive Pills Market Size (US$ Million), 2021–2032
Figure 14. Global Long-Acting Contraceptive Pills Sales (K Units), 2021–2032
Figure 15. Global Long-Acting Contraceptive Pills Average Price (US$/Unit), 2021–2032
Figure 16. Long-Acting Contraceptive Pills Report Years Considered
Figure 17. Long-Acting Contraceptive Pills Sales Share by Manufacturers in 2025
Figure 18. Global Long-Acting Contraceptive Pills Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Long-Acting Contraceptive Pills Players: Market Share by Revenue in Long-Acting Contraceptive Pills in 2025
Figure 20. Long-Acting Contraceptive Pills Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Long-Acting Contraceptive Pills Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Long-Acting Contraceptive Pills Sales Market Share by Country (2021–2032)
Figure 23. North America Long-Acting Contraceptive Pills Revenue Market Share by Country (2021–2032)
Figure 24. United States Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Long-Acting Contraceptive Pills Sales Market Share by Country (2021–2032)
Figure 27. Europe Long-Acting Contraceptive Pills Revenue Market Share by Country (2021–2032)
Figure 28. Germany Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Long-Acting Contraceptive Pills Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Long-Acting Contraceptive Pills Revenue Market Share by Region (2021–2032)
Figure 35. China Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Long-Acting Contraceptive Pills Sales Market Share by Country (2021–2032)
Figure 43. Latin America Long-Acting Contraceptive Pills Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Long-Acting Contraceptive Pills Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Long-Acting Contraceptive Pills Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Long-Acting Contraceptive Pills by Type (2021–2032)
Figure 54. Global Revenue Market Share of Long-Acting Contraceptive Pills by Type (2021–2032)
Figure 55. Global Long-Acting Contraceptive Pills Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Long-Acting Contraceptive Pills by Application (2021–2032)
Figure 57. Global Revenue Market Share of Long-Acting Contraceptive Pills by Application (2021–2032)
Figure 58. Global Long-Acting Contraceptive Pills Price (US$/Unit) by Application (2021–2032)
Figure 59. Long-Acting Contraceptive Pills Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Long-Acting Contraceptive Pills Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Long-Acting Contraceptive Pills Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Long-Acting Contraceptive Pills Market Competitive Situation by Manufacturers in 2025
Table 4. Global Long-Acting Contraceptive Pills Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Long-Acting Contraceptive Pills Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Long-Acting Contraceptive Pills Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Long-Acting Contraceptive Pills Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Long-Acting Contraceptive Pills Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Long-Acting Contraceptive Pills, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Long-Acting Contraceptive Pills, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Long-Acting Contraceptive Pills, Product Types and Applications
Table 12. Global Key Manufacturers of Long-Acting Contraceptive Pills, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Long-Acting Contraceptive Pills Companies by Tier (Tier 1, Tier 2, Tier 3), based on Long-Acting Contraceptive Pills Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Long-Acting Contraceptive Pills Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Long-Acting Contraceptive Pills Sales by Region (K Units), 2021–2026
Table 18. Global Long-Acting Contraceptive Pills Sales Market Share by Region (2021–2026)
Table 19. Global Long-Acting Contraceptive Pills Sales by Region (K Units), 2027–2032
Table 20. Global Long-Acting Contraceptive Pills Sales Market Share by Region (2027–2032)
Table 21. Global Long-Acting Contraceptive Pills Revenue by Region (US$ Million), 2021–2026
Table 22. Global Long-Acting Contraceptive Pills Revenue Market Share by Region (2021–2026)
Table 23. Global Long-Acting Contraceptive Pills Revenue by Region (US$ Million), 2027–2032
Table 24. Global Long-Acting Contraceptive Pills Revenue Market Share by Region (2027–2032)
Table 25. North America Long-Acting Contraceptive Pills Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Long-Acting Contraceptive Pills Sales by Country (K Units), 2021–2026
Table 27. North America Long-Acting Contraceptive Pills Sales by Country (K Units), 2027–2032
Table 28. North America Long-Acting Contraceptive Pills Revenue by Country (US$ Million), 2021–2026
Table 29. North America Long-Acting Contraceptive Pills Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Long-Acting Contraceptive Pills Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Long-Acting Contraceptive Pills Sales by Country (K Units), 2021–2026
Table 32. Europe Long-Acting Contraceptive Pills Sales by Country (K Units), 2027–2032
Table 33. Europe Long-Acting Contraceptive Pills Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Long-Acting Contraceptive Pills Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Long-Acting Contraceptive Pills Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Long-Acting Contraceptive Pills Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Long-Acting Contraceptive Pills Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Long-Acting Contraceptive Pills Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Long-Acting Contraceptive Pills Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Long-Acting Contraceptive Pills Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Long-Acting Contraceptive Pills Sales by Country (K Units), 2021–2026
Table 42. Latin America Long-Acting Contraceptive Pills Sales by Country (K Units), 2027–2032
Table 43. Latin America Long-Acting Contraceptive Pills Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Long-Acting Contraceptive Pills Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Long-Acting Contraceptive Pills Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Long-Acting Contraceptive Pills Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Long-Acting Contraceptive Pills Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Long-Acting Contraceptive Pills Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Long-Acting Contraceptive Pills Revenue by Country (US$ Million), 2027–2032
Table 50. Global Long-Acting Contraceptive Pills Sales (K Units) by Type (2021–2026)
Table 51. Global Long-Acting Contraceptive Pills Sales (K Units) by Type (2027–2032)
Table 52. Global Long-Acting Contraceptive Pills Sales Market Share by Type (2021–2026)
Table 53. Global Long-Acting Contraceptive Pills Sales Market Share by Type (2027–2032)
Table 54. Global Long-Acting Contraceptive Pills Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Long-Acting Contraceptive Pills Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Long-Acting Contraceptive Pills Revenue Market Share by Type (2021–2026)
Table 57. Global Long-Acting Contraceptive Pills Revenue Market Share by Type (2027–2032)
Table 58. Global Long-Acting Contraceptive Pills Price (US$/Unit) by Type (2021–2026)
Table 59. Global Long-Acting Contraceptive Pills Price (US$/Unit) by Type (2027–2032)
Table 60. Global Long-Acting Contraceptive Pills Sales (K Units) by Application (2021–2026)
Table 61. Global Long-Acting Contraceptive Pills Sales (K Units) by Application (2027–2032)
Table 62. Global Long-Acting Contraceptive Pills Sales Market Share by Application (2021–2026)
Table 63. Global Long-Acting Contraceptive Pills Sales Market Share by Application (2027–2032)
Table 64. Global Long-Acting Contraceptive Pills Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Long-Acting Contraceptive Pills Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Long-Acting Contraceptive Pills Revenue Market Share by Application (2021–2026)
Table 67. Global Long-Acting Contraceptive Pills Revenue Market Share by Application (2027–2032)
Table 68. Global Long-Acting Contraceptive Pills Price (US$/Unit) by Application (2021–2026)
Table 69. Global Long-Acting Contraceptive Pills Price (US$/Unit) by Application (2027–2032)
Table 70. Zhejiang Xianju Pharmaceutical Company Information
Table 71. Zhejiang Xianju Pharmaceutical Description and Business Overview
Table 72. Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Product
Table 74. Zhejiang Xianju Pharmaceutical Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Pfizer Long-Acting Contraceptive Pills Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Mylan Company Information
Table 81. Mylan Description and Business Overview
Table 82. Mylan Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Mylan Long-Acting Contraceptive Pills Product
Table 84. Mylan Recent Developments/Updates
Table 85. Teva Pharmaceuticals Company Information
Table 86. Teva Pharmaceuticals Description and Business Overview
Table 87. Teva Pharmaceuticals Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Teva Pharmaceuticals Long-Acting Contraceptive Pills Product
Table 89. Teva Pharmaceuticals Recent Developments/Updates
Table 90. Cipla Company Information
Table 91. Cipla Description and Business Overview
Table 92. Cipla Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Cipla Long-Acting Contraceptive Pills Product
Table 94. Cipla Recent Developments/Updates
Table 95. Bayer Company Information
Table 96. Bayer Description and Business Overview
Table 97. Bayer Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Bayer Long-Acting Contraceptive Pills Product
Table 99. Bayer Recent Developments/Updates
Table 100. Merck Company Information
Table 101. Merck Description and Business Overview
Table 102. Merck Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Merck Long-Acting Contraceptive Pills Product
Table 104. Merck Recent Developments/Updates
Table 105. Sun Pharma Company Information
Table 106. Sun Pharma Description and Business Overview
Table 107. Sun Pharma Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Sun Pharma Long-Acting Contraceptive Pills Product
Table 109. Sun Pharma Recent Developments/Updates
Table 110. Shanghai Pharmaceuticals Company Information
Table 111. Shanghai Pharmaceuticals Description and Business Overview
Table 112. Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Product
Table 114. Shanghai Pharmaceuticals Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Long-Acting Contraceptive Pills Distributors List
Table 118. Long-Acting Contraceptive Pills Customers List
Table 119. Long-Acting Contraceptive Pills Market Trends
Table 120. Long-Acting Contraceptive Pills Market Drivers
Table 121. Long-Acting Contraceptive Pills Market Challenges
Table 122. Long-Acting Contraceptive Pills Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Long-Acting Contraceptive Pills
Figure 2. Global Long-Acting Contraceptive Pills Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Long-Acting Contraceptive Pills Market Share by Type: 2025 & 2032
Figure 4. Injectables Product Picture
Figure 5. Subdermal Implants Product Picture
Figure 6. Intrauterine Devices Product Picture
Figure 7. Other Product Picture
Figure 8. Global Long-Acting Contraceptive Pills Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Long-Acting Contraceptive Pills Market Share by Application: 2025 & 2032
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Global Long-Acting Contraceptive Pills Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Long-Acting Contraceptive Pills Market Size (US$ Million), 2021–2032
Figure 14. Global Long-Acting Contraceptive Pills Sales (K Units), 2021–2032
Figure 15. Global Long-Acting Contraceptive Pills Average Price (US$/Unit), 2021–2032
Figure 16. Long-Acting Contraceptive Pills Report Years Considered
Figure 17. Long-Acting Contraceptive Pills Sales Share by Manufacturers in 2025
Figure 18. Global Long-Acting Contraceptive Pills Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Long-Acting Contraceptive Pills Players: Market Share by Revenue in Long-Acting Contraceptive Pills in 2025
Figure 20. Long-Acting Contraceptive Pills Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Long-Acting Contraceptive Pills Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Long-Acting Contraceptive Pills Sales Market Share by Country (2021–2032)
Figure 23. North America Long-Acting Contraceptive Pills Revenue Market Share by Country (2021–2032)
Figure 24. United States Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Long-Acting Contraceptive Pills Sales Market Share by Country (2021–2032)
Figure 27. Europe Long-Acting Contraceptive Pills Revenue Market Share by Country (2021–2032)
Figure 28. Germany Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Long-Acting Contraceptive Pills Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Long-Acting Contraceptive Pills Revenue Market Share by Region (2021–2032)
Figure 35. China Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Long-Acting Contraceptive Pills Sales Market Share by Country (2021–2032)
Figure 43. Latin America Long-Acting Contraceptive Pills Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Long-Acting Contraceptive Pills Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Long-Acting Contraceptive Pills Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Long-Acting Contraceptive Pills Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Long-Acting Contraceptive Pills by Type (2021–2032)
Figure 54. Global Revenue Market Share of Long-Acting Contraceptive Pills by Type (2021–2032)
Figure 55. Global Long-Acting Contraceptive Pills Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Long-Acting Contraceptive Pills by Application (2021–2032)
Figure 57. Global Revenue Market Share of Long-Acting Contraceptive Pills by Application (2021–2032)
Figure 58. Global Long-Acting Contraceptive Pills Price (US$/Unit) by Application (2021–2032)
Figure 59. Long-Acting Contraceptive Pills Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232